Oncotarget: Can Precision Oncology Improve Patient Survival AND Cut Costs?

(45)

WNT-Pathway Medulloblastoma: What Constitutes Low-Risk and How Low Can One Go? | Oncotarget

(2:37)

AI's Role in Advancing Intratumoral Immunotherapy | Oncotarget

(1:43)

Oncotarget: Epigenetic feedback and stochastic partitioning can drive resistance to EMT

(19:30)

Enhancing DNA Damage and Immunotherapy by Starving Cancer Cells | Oncotarget

(1:36)

Oncotarget: Novel insights into the prognostic evaluation of prostate cancer

(29:15)

Zika Virus as a Treatment for Brain Cancer: A Systematic Review | Oncotarget

(2:34)

Oncotarget: Targeted Ovarian Cancer Treatment

(50)

Hepatocellular carcinoma - Pathology || Easy explaination || MBBS

(5:)

Oncotarget: Osteoprotegerin rich tumor microenvironment: implications in breast cancer

(4:54)

FERROPTOSIS : Iron dependent Programmed cell death. Mechanism , Applications.

(14:45)

Inhibition of Glutamine Metabolism: Acting on Tumoral Cells or Tumor Microenvironment? | Oncotarget

(1:34)

Regulated Transcription Controlled by Oxygen and HIF 1Alpha

(2:55)

Oncotarget: Significant differences in biomarker expression in pancreatic cancer

(11:36)

Oncotarget: ONC201 kills breast cancer cells in vitro by targeting mitochondria

(12:54)

HER3: A Vital Target in Cancer Treatment | Oncotarget

(8:49)

Oncotarget | Findings offer new clues for targeting drug resistant colon cancers

(7:7)

Iron Chelation Therapy (2/2) 【USMLE/ Pharmacology】

(2:21)

Oncotarget | Reversing Oncogenic Transformation With Iron Chelation

(59)

Sacituzumab Govitecan with Platinum Chemotherapy: Antitumor Effects | Oncotarget

(2:17)

Next-Gen Cell-Penetrating Antibodies for Tumor Targeting and RAD51 Inhibition | Oncotarget

(1:30)

The Nuclear Envelope and Metastasis | Oncotarget

(1:4)

Oncotarget: Smurf2 Regulation of HIF-1α in Cancer Cells

(46)

Generative AI in Cancer Imaging: Revolutionizing Detection \u0026 Diagnosis | Oncotarget

(1:6)

Genomics Has More to Reveal | Oncotarget

(1:27)

Validation of NeXT Personal®: Ultra-Sensitive ctDNA Assay | Oncotarget

(2:3)

Systemic Treatment for Brain Metastasis in HER2-Positive Advanced Breast Cancer | Oncotarget

(1:18)

Breakthroughs in Cell-Penetrating Monoclonal Antibody Therapies | Oncotarget

(1:38)

Oncotarget: Targeting mesothelin with high cytotoxic activity

(6:52)